Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01954173 · ClinicalTrials.gov registry record · NA
Adjuvant Radiation for High Risk Bladder Cancer
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01954173 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 19 participants.
The verdict
NCT01954173, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This phase II trial studies how well modern, conformal radiation therapy after surgery works in treating patients with high-risk bladder cancer. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.
Interventions
- RADIATION 3D conformal radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2013-07-22 |
| Est. Completion | 2021-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01954173
The ClinicalTrials.gov registry entry for NCT01954173 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 3D conformal radiation therapy is the first listed.
NCT01954173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01954173 about?
NCT01954173 is a clinical study titled "Adjuvant Radiation for High Risk Bladder Cancer". This phase II trial studies how well modern, conformal radiation therapy after surgery works in treating patients with high-risk bladder cancer. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue...
What is the current status of trial NCT01954173?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2013-07-22. Estimated completion is 2021-09-20.
What interventions are being tested in trial NCT01954173?
The interventions under investigation include: 3D conformal radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT01954173?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.